A cartoon of the globe with human lungs at the center of the globe and sources of air pollution on the perimeter.

To respond to the threat of avian influenza, look back at lessons from COVID-19

Tackling an avian influenza virus strain with pandemic potential should be straightforward — if lessons from the COVID-19 pandemic are heeded.

Editorial

Announcements

  • People of different ages and backgrounds coming together to form a healthy population

    Women’s health has been underfunded and underprioritized for too long, leading to delays in diagnosis and poor health outcomes. This series will bring together a range of viewpoints and new research focusing on the causes of ill health in women and the barriers to their health and wellbeing in the 21st Century.

  • Africa

    Join us for this free-to-attend, in-person conference in Nairobi, Kenya, catalyzing collaboration and driving change. Attendees will delve into cutting-edge scientific breakthroughs surrounding the epidemiology of dementia, the contributing risk factors and genetics, and advancements in early detection and diagnosis of dementia in Africa and globally.

  • dei series

    This ongoing series brings together a range of viewpoints on DEI in medical research, covering topics such as funding biases, workforce diversity and how to fix the lack of diversity of health data. Reach out to us to contribute your perspective.

Nature Medicine is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.

Advertisement

  • For precision genetic medicines to fulfill their potential as treatments for ultra-rare diseases, fresh approaches to academic–industry partnerships and data sharing are needed, together with regulatory change and adaptation of reimbursement models.

    • Julia M. Y. Pian
    • Nana Owusu
    • Timothy W. Yu
    Comment
  • The phase 3 NADINA trial showed impressive responses to neoadjuvant nivolumab plus ipilimumab relative to adjuvant nivolumab (the current best practice), revealing a new standard of care for patients with stage III melanoma.

    • Karen O’Leary
    Research Highlight
  • Juliane Fonseca de Oliveira is a mathematician at CIDACS in Salvador, Bahia, Brazil. She describes her part in building an epidemiological model to analyze the diverse populations within the 100 Million Brazilians Cohort.

    • Juliane Fonseca de Oliveira
    Turning Points

Nature Careers

Science jobs

Advertisement